Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
(“Faron” or “the Company”) Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board Company Announcement, 5 November 2024 TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces that the following members have been appointed by a meeting of the Company's five largest shareholders to Faron Pharmaceuticals Oy’s Shareholders' Nomination Board: · Timo Syrjälä, representing himself (Chair) · Erkka Kohonen,